Biohaven
BHVN· Manufacturing· Fiscal year ends in December
CEO pay in FY2025
Vlad Coric, M.D. is the CEO of Biohaven and was paid $13.5M in FY2025 (Dec), up 29%.
PayNo stock prices for these years
Executives4
See all- 1Vlad Coric, M.D.Chief Executive OfficerFY2025
- 2Bruce CarChief Scientific OfficerFY2025
- 3Matthew ButenChief Financial OfficerFY2025
- 4Kimberly GentileSenior Vice President, Clinical OperationsFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBiohaven paid its 4 named executives $26.7M in total in FY2025 (Dec). CEO Vlad Coric, M.D. was paid $13.5M of that.
| Name | |||
|---|---|---|---|
| Vlad Coric, M.D.Chief Executive Officer | |||
| Bruce CarChief Scientific Officer | |||
| Matthew ButenChief Financial Officer | |||
| Kimberly GentileSenior Vice President, Clinical Operations |
of each named executive, from the Summary Compensation Table of each proxy.
Peers21
See all
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board2
See all- Irina AntonijevicDirector · 3 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive
- Julia P. GregoryDirector · 3 yr on the boardIndependentAudit (Chair)—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Mar 13, 2026 | FY2025 |
| Annual report | 10-K | Mar 2, 2026 | FY2025 |
| Proxy statement | DEF 14A | Mar 18, 2025 | FY2024 |
| Annual report | 10-K | Mar 3, 2025 | FY2024 |
| Proxy statement | DEF 14A | Mar 18, 2024 | FY2023 |
| Annual report | 10-K | Feb 29, 2024 | FY2023 |
